臨床眼科76巻13号

2022年12月発行

特集 ゲノム解析の「今」と「これから」—解析結果は眼科診療に何をもたらすか

加齢黄斑変性症のゲノム解析とリスク評価および治療開発への布石

著者： 本田茂¹

所属機関： ¹大阪公立大学大学院医学研究科視覚病態学

ページ範囲：P.1672 - P.1679

●加齢黄斑変性症は遺伝要因が大きく絡む疾患である。

●ゲノム解析によって疾患の発症予測や病態解明が可能となった。

●疾患の分子病態解明により新たな治療薬開発や個別化医療の発展が期待できる。

参考文献

1）Haines JL, Hauser MA, Schmidt S et al：Complement factor H variant increases the risk of age-related macular degeneration. Science 308：419-421, 2005

2）Maller J, George S, Purcell S et al：Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38：1055-1059, 2006

3）Kondo N, Bessho H, Honda S et al：Complement factor H Y402H variant and risk of age-related macular degeneration in Asians：a systematic review and meta-analysis. Ophthalmology 118：339-344, 2011

4）Fisher DE, Klein BEK, Wong TY et al：Incidence of age-related macular degeneration in a multi-ethnic United States population：the multi-ethnic study of atherosclerosis. Ophthalmology 123：1297-1308, 2016

5）Hayashi H, Yamashiro K, Gotoh N et al：CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 51：5914-5919, 2010

as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci U S A 115：6261-6266, 2018

7）Miki A, Kondo N, Yanagisawa S et al：Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 121：1067-1072, 2014

8）Kondo N, Honda S, Kuno S et al：Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. Ophthalmology 116：304-310, 2009

9）Dewan A, Liu M, Hartman S et al：HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314：989-992, 2006

10）Yang Z, Camp NJ, Sun H et al：A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314：992-993, 2006

11）Mori K, Horie-Inoue K, Kohda M et al：Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population. J Hum Genet 52：636-641, 2007

12）Kondo N, Honda S, Ishibashi K et al：LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 144：608-612, 2007

13）Vierkotten S, Muether PS, Fauser S：Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS One. doi：10.1371/journal.pone.0022959, 2011

14）Kumar S, Berriochoa Z, Ambati BK et al：Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium. Invest Ophthalmol Vis Sci 55：3842-3850, 2014

15）Nakayama M, Iejima D, Akahori M et al：Overexpression of HtrA1 and exposure to mainstream cigarette smoke leads to choroidal neovascularization and subretinal deposits in aged mice. Invest Ophthalmol Vis Sci 55：6514-6523, 2014

16）Dietzel M, Pauleikhoff D, Arning A et al：The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 252：1273-1281, 2014

17）Farwick A, Dasch B, Weber BH et al：Variations in five genes and the severity of age-related macular degeneration：results from the Muenster aging and retina study. Eye（Lond）23：2238-2244, 2009

18）Sakurada Y, Kubota T, Imasawa M et al：Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy. Retina 29：1522-1526, 2009

19）Yanagisawa S, Kondo N, Miki A et al：Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene（ARMS2）. Mol Vis 17：3574-3582, 2011

20）Hosoda Y, Yamashiro K, Miyake M et al：Predictive genes for the prognosis of central serous chorioretinopathy. Ophthalmol Retina 3：985-992, 2019

21）Mori Y, Miyake M, Hosoda Y et al：Genome-wide survival analysis for macular neovascularization development in central serous chorioretinopathy revealed shared genetic susceptibility with polypoidal choroidal vasculopathy. Ophthalmology 129：1034-1042, 2022

22）Arakawa S, Takahashi A, Ashikawa K et al：Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet 43：1001-1004, 2011

23）Hosoda Y, Miyake M, Schellevis RL et al：Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. Commun Biol. doi：10.1038/s42003-019-0712-z, 2019

24）Yamashiro K, Mori K, Honda S et al：A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration. Sci Rep. doi：10.1038/s41598-017-09632-0, 2017

25）Riaz M, Lorés-Motta L, Richardson AJ et al：GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration. Sci Rep. doi：10.1038/srep37924, 2016

26）Lorés-Motta L, Riaz M, Grunin M et al：Association of genetic variants with response to anti-vascular endothelial growth factor therapy in age-related macular degeneration. JAMA Ophthalmol 136：875-884, 2018

27）Akiyama M, Takahashi A, Momozawa Y et al：Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration. J Hum Genet 63：1083-1091, 2018

28）Strunz T, Pöllmann M, Gamulescu MA et al：Genetic association analysis of anti-VEGF treatment response in neovascular age-related macular degeneration. Int J Mol Sci 23：6094, 2022

29）Balikova I, Postelmans L, Pasteels B et al：Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration. BMJ Open Ophthalmol. doi：10.1136/bmjophth-2019-000273, 2019

30）Nakai S, Honda S, Matsumiya W et al：ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration. Mol Vis 23：514-519, 2017